Skip to main content
logo
Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.9240
-0.0860 (-8.51%)
Oct 27, 2026, 4:00 PM EDT - Market closed

Purple Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cost of Revenue
0.060.060.060.20.120.06
Gross Profit
-0.06-0.06-0.06-0.2-0.12-0.06
Selling, General & Admin
3.483.193.125.046.166.04
Research & Development
4.353.737.6217.0316.3211.83
Operating Expenses
7.836.9210.7422.0822.4817.87
Operating Income
-7.89-6.98-10.8-22.27-22.6-17.92
Interest & Investment Income
0.20.230.260.470.530.32
Currency Exchange Gain (Loss)
0.010.01-0.01-0.010.06-0.13
Other Non Operating Income (Expenses)
3.570.733.481.830.25-0.08
EBT Excluding Unusual Items
-4.11-6.01-7.08-19.98-21.76-17.81
Asset Writedown
-20.48-20.48-0.2---
Legal Settlements
------0.01
Pretax Income
-24.6-26.49-7.28-19.98-21.76-17.83
Earnings From Continuing Operations
-24.6-26.49-7.28-19.98-21.76-17.83
Earnings From Discontinued Operations
------0.64
Net Income to Company
-24.6-26.49-7.28-19.98-21.76-18.47
Minority Interest in Earnings
0.10.110.040.10.090.08
Net Income
-24.49-26.39-7.24-19.88-21.67-18.38
Net Income to Common
-24.49-26.39-7.24-19.88-21.67-18.38
Net Income Growth
------
Shares Outstanding (Basic)
1,700960328221181176
Shares Outstanding (Diluted)
1,700960328221181176
Shares Change
267.67%192.79%48.15%22.41%2.92%52.76%
EPS (Basic)
-0.01-0.03-0.02-0.09-0.12-0.10
EPS (Diluted)
-0.01-0.03-0.02-0.09-0.12-0.10
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7.76-5.66-14.37-19.93-16.76-15.37
Free Cash Flow Per Share
-0.01-0.01-0.04-0.09-0.09-0.09
EBITDA
-7.84-6.97-10.77-22.07-22.4-17.69
D&A For EBITDA
0.0500.030.20.20.23
EBIT
-7.89-6.98-10.8-22.27-22.6-17.92
SEC Filings: 10-K · 10-Q